MentionFox
Home › funding signals › HistoWiz
Accelerator · announced

HistoWiz (YC W16) — Accelerating histopathology for cancer research

HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise.

HistoWiz is a Y Combinator company in the Winter 2016 batch. Its directory entry describes it as: Accelerating Histopathology for Cancer Research. The founder listed is Ke Cheng (Founder/CEO) (Y Combinator directory entry, November 16, 2015).

6 more companies from YC Winter 2016 ↓

Run the free check on HistoWiz →

Sell to companies like HistoWiz? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

HistoWiz

New accelerator entry · 2015-11-16 · the record

Winter 2016
batch
2
people
Growth
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2016
Announced2015-11-16
StageGrowth
StatusActive
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Healthcare Services
SectorsBiotech, AI
RegionsUnited States of America, America / Canada
BasedNew York City, NY, USA; Brooklyn, NY, USA
HiringNo
Sitehttp://histowiz.com

Pitching, partnering or investing alongside them? See who really runs and owns HistoWiz.

Free to see. No signup.

Keep reading

More on HistoWiz and the records around it.

Also in YC Winter 2016

Same batch, Healthcare first.

What do you want to do with HistoWiz?

Get the full cited report on HistoWiz

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on HistoWiz: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among medical scientists and research pathologists. HistoWiz's mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. The HistoWiz advantage We help your lab minimize the cost of research and maximize research productivity by providing the most efficient service for scientists to analyze experimental pathology specimens. We believe that scientists should spend their time on results interpretation rather than repetitive tissue cutting. How does it work? HistoWiz accepts formalin-fixed specimens by mail for tissue processing services. To expedite delivery of results and to facilitate global collaboration, HistoWiz offers whole-slide imaging and pathology services, allowing researchers to remotely and instantly view high-magnification images of their specimens via a secure, cloud-based “virtual microscope” on any computer or mobile device without downloading any software or gigabyte-sized files.

Want the whole picture on HistoWiz?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on HistoWiz: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on HistoWiz covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind HistoWiz: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for HistoWiz. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

HistoWiz: Accepted into Y Combinator Winter 2016
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-histowiz
Last updated 2026-10-20
Primary record: Y Combinator directory entry
HistoWiz (YC W16) — Accelerating histopathology for cancer research. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-histowiz